A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Last month, I briefly covered the topic of bladder cancer, looking at the causes and symptoms of this disease. This month, I ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called ...

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...

Groundbreaking study published in The Journal of Molecular Diagnostics paves the way for noninvasive screening tools that improve patient comfort and outcomes Bladder cancer remains a major clinical ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

New Urine Test Could Predict Response To Bladder Cancer Treatment. Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has residual bladder cancer after ...

Pfizer (NYSE:PFE) received U.S. FDA Priority Review for a supplemental Biologics License Application covering PADCEV plus ...

Doctors are urging the public to seek medical advice when abnormal symptoms arise, following the death of local marathoner ...